What is GeneTether Therapeutics Inc. (GTTX.CN)?

GeneTether Therapeutics Inc. (GTTX.CN) is a stock in the Healthcare sector, Biotechnology industry. View full analysis on Stocks360.

GeneTether Therapeutics Inc. (GTTX.CN)

Stock analysis · CNQ · Healthcare · Biotechnology

Market Cap

N/A

PE (TTM)

N/A

EPS (TTM)

N/A

Dividend Yield

N/A

Beta

-1.56

Day Range

N/A

52-wk Range

N/A

Avg Volume

N/A

Volume

N/A

GeneTether Therapeutics Inc. (GTTX.CN) is a publicly traded company in the Healthcare sector. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Proprietary Signals

Signal snapshot temporarily unavailable.

About GeneTether Therapeutics Inc.

GeneTether Therapeutics Inc. (GTTX.CN) is a biotechnology firm specializing in genetic medicines. Its primary focus is the advancement of gene-editing therapies, aiming to significantly boost the effectiveness of current genomic modification techniques. The company's pipeline is dedicated to engineering genetic treatments for individuals suffering from rare, single-gene disorders affecting the kidneys and skin. Established in 2018, GeneTether Therapeutics Inc. is headquartered in Kelowna, Canada.